Brainstorm Cell Therapeutics Inc (BCLI)
0.5712
-0.05
(-7.87%)
USD |
NASDAQ |
May 22, 16:00
0.598
+0.03
(+4.69%)
After-Hours: 20:00
Brainstorm Cell Therapeutics 1 Year Total Returns (Daily): -78.25% for May 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 21, 2024 | -78.25% |
May 20, 2024 | -80.11% |
May 17, 2024 | -81.16% |
May 16, 2024 | -80.89% |
May 15, 2024 | -82.46% |
May 14, 2024 | -81.88% |
May 13, 2024 | -80.14% |
May 10, 2024 | -84.65% |
May 09, 2024 | -83.61% |
May 08, 2024 | -85.37% |
May 07, 2024 | -87.69% |
May 06, 2024 | -87.49% |
May 03, 2024 | -87.66% |
May 02, 2024 | -86.72% |
May 01, 2024 | -85.47% |
April 30, 2024 | -86.94% |
April 29, 2024 | -81.33% |
April 26, 2024 | -80.91% |
April 25, 2024 | -80.86% |
April 24, 2024 | -82.13% |
April 23, 2024 | -82.79% |
April 22, 2024 | -82.29% |
April 19, 2024 | -79.62% |
April 18, 2024 | -80.74% |
April 17, 2024 | -79.28% |
Date | Value |
---|---|
April 16, 2024 | -81.24% |
April 15, 2024 | -80.47% |
April 12, 2024 | -77.79% |
April 11, 2024 | -79.82% |
April 10, 2024 | -78.89% |
April 09, 2024 | -79.27% |
April 08, 2024 | -74.02% |
April 05, 2024 | -76.91% |
April 04, 2024 | -74.72% |
April 03, 2024 | -76.95% |
April 02, 2024 | -78.21% |
April 01, 2024 | -77.58% |
March 28, 2024 | -69.31% |
March 27, 2024 | -62.49% |
March 26, 2024 | -57.42% |
March 25, 2024 | -57.74% |
March 22, 2024 | -63.23% |
March 21, 2024 | -70.55% |
March 20, 2024 | -68.31% |
March 19, 2024 | -77.91% |
March 18, 2024 | -79.60% |
March 15, 2024 | -79.45% |
March 14, 2024 | -79.20% |
March 13, 2024 | -78.67% |
March 12, 2024 | -80.98% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.15%
Minimum
Oct 03 2023
358.1%
Maximum
Oct 08 2020
-1.71%
Average
-19.11%
Median
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -82.71% |
Palatin Technologies Inc | -17.53% |
iBio Inc | -87.70% |
Theriva Biologics Inc | -45.59% |
Oragenics Inc | 1.67% |